Radwa E. Mahgoub
Al Ain, AZ, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of Putative Equilibrative Nucleoside Transporter Inhibitors Through Dual-Pharmacophore Virtual Screening and Validation in a Gemcitabine-Based Cell Assay.
Journal: Molecules (Basel, Switzerland)
Published: February 25, 2026
Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach.
Journal: Drug design, development and therapy
Published: January 01, 2026
The Discovery of Small ERK5 Inhibitors via Structure-Based Virtual Screening, Biological Evaluation and MD Simulations.
Journal: Molecules (Basel, Switzerland)
Published: September 01, 2025
Evaluation of the functional impact of rare CYP2C19 missense variants identified in understudied Populations: An Integrated in silico and in vitro analysis.
Journal: Biochemical pharmacology
Published: June 11, 2025
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 06, 2025
Cellular and functional evaluation of LDLR missense variants reported in hypercholesterolemic patients demonstrates their hypomorphic impacts on trafficking and LDL internalization.
Journal: Frontiers in cell and developmental biology
Published: April 04, 2024
Discovery of pyrimidoindol and benzylpyrrolyl inhibitors targeting SARS-CoV-2 main protease (Mpro) through pharmacophore modelling, covalent docking, and biological evaluation.
Journal: Journal of molecular graphics & modelling
Published: September 15, 2023
The Discovery of Novel Small Oxindole-Based Inhibitors Targeting the SARS-CoV-2 Main Protease (Mpro ).
Journal: Chemistry & biodiversity
Published: August 07, 2023
Molecular Modelling Study and Antibacterial Evaluation of Diphenylmethane Derivatives as Potential FabI Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: February 14, 2023
The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: August 31, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026